If you're right, then LYC Bioscience gets everything "bioamber" including its debts, secured or non-secured, which partially explains the Mitsui entry into consideration. There had to be a "compensation" clause in their opt out, designed to facilitate the operation and/or survival of all things bioamber ... among other emerging details since the Eno's stock purchase and the Board's resignation. BIOA stock becomes whatever symbol FINRA agrees to when the sale is absolutely completed and all outstanding issues resolved.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.